Novel Small Molecule Targeting Huntington’s Disease Is Ready for Clinical Trials Planegg, Martinsried, Germany, May 10, 2021 (GLOBE NEWSWIRE) -- Bicoll, an expert in synthesizing new and relevant small molecules as starting points for accelerated drug development, announced...